Grupo Interdisciplinario de Investigación en Epidemiología y Salud Pública, Universidad Libre, Cali, Colombia.
rupo de Investigación de Microbiología, Industria y Medio Ambiente, Universidad Santiago de Cali, Cali, Colombia.
Biomedica. 2023 Sep 30;43(3):360-373. doi: 10.7705/biomedica.6961.
Introduction. The success rates in the treatment of tuberculosis are suboptimal. Objective. To identify associated factors with the lack of success of antituberculosis treatment in patients with a tuberculosis treatment history. Materials and methods. We performed a retrospective, analytical, observational, and cohort study of patients reentering the Mycobacterium program in Cali, Colombia. We included patients over 15 years old with pulmonary tuberculosis between 2015 and 2019 and a history of tuberculosis treatment. Patients with drug-resistant tuberculosis were excluded. Results. A total of 605 patients with a treatment history were included, 60% due to unfinished treatment and 40% due to relapse. Compared to patients reentering due to relapse (ORa=2.34, CI=1.62-3.38), the independent variables associated with treatment failure at discharge were homelessness (ORa=2.45, CI=1.54-3.89), substance dependence (ORa=1.95, CI=1.24-3.05), tuberculosis/HIV coinfection (ORa=1.69, CI=1.00-2.86), diabetes (ORa=1.89, CI=1.29-2.77), and unfinished previous tuberculosis treatment due to follow-up loss, abandonment, or other causes. Programmatic variables favoring treatment success were voluntary HIV testing counseling (p<0.001) and HIV testing (p<0.001). Conclusion. Homelessness, substance dependence, tuberculosis/HIV coinfection, diabetes, and incomplete previous treatment due to loss to follow-up, abandonment, or treatment failure hindered the success of antituberculosis. These characteristics should be identified and addressed during the initial care of patients reentering treatment for tuberculosis.
引言。结核病治疗的成功率并不理想。目的。确定与既往结核病治疗患者抗结核治疗失败相关的因素。材料与方法。我们对哥伦比亚卡利重新进入结核分枝杆菌项目的患者进行了回顾性、分析性、观察性和队列研究。我们纳入了 2015 年至 2019 年间患有肺结核且有结核病治疗史的 15 岁以上患者。排除耐药结核病患者。结果。共纳入 605 例有治疗史的患者,60%是由于治疗未完成,40%是由于复发。与因复发而重新进入治疗的患者相比(ORa=2.34,95%CI=1.62-3.38),与出院时治疗失败相关的独立变量包括无家可归(ORa=2.45,95%CI=1.54-3.89)、物质依赖(ORa=1.95,95%CI=1.24-3.05)、结核/艾滋病合并感染(ORa=1.69,95%CI=1.00-2.86)、糖尿病(ORa=1.89,95%CI=1.29-2.77)以及因随访丢失、放弃或其他原因导致未完成既往结核病治疗。有利于治疗成功的方案变量是自愿艾滋病毒检测咨询(p<0.001)和艾滋病毒检测(p<0.001)。结论。无家可归、物质依赖、结核/艾滋病合并感染、糖尿病以及因随访丢失、放弃或治疗失败导致的未完成既往治疗会阻碍抗结核治疗的成功。在重新开始结核病治疗的患者的初始护理中,应识别和解决这些特征。